twitter Tweet

Brain Awareness lecture series begins May 6

CALENDAR ALERT: Mindfulness, mushrooms, complementary and alternative methods to inspire behavioral change are focus of presentations



OHSU Brain Awareness lecture series


7 p.m. Mondays: May 6, 13, 20


Newmark Theatre, 1111 S.W. Broadway, Portland


Can we rewire and heal our brains using natural, alternative treatments? This year’s Brain Awareness lectures explore the influence of the mind-body connection on such challenges as addiction, psychosis and end-of-life anxiety. Top national neuroscience researchers will talk about complementary and alternative methods to overcome negative emotional and psychological cycles.

Hosted by the OHSU Brain Institute, the Brain Awareness lecture series began in 2000.


Good vibes only: Treating addiction with mindfulness (May 6)

front facing image of woman smiling at camera
Katie Witkiewitz, Ph.D.

Can using mindfulness and meditation techniques help people reduce the intake of harmful substances and prevent relapse? Katie Witkiewitz, Ph.D., is a Regents’ professor of psychology at the University of New Mexico with a joint appointment at the Center on Alcoholism, Substance Abuse, and Addictions. A licensed clinical psychologist, Witkiewitz has studied models of addiction and evaluated the success of mindfulness-based therapies.


Lifestyle tweaks for teen psychosis (May 13)

front facing image of woman smiling at camera
Lynne Shinto, N.D., M.P.H.

For teens with schizophrenia-spectrum disorders, the medication they need can also lead to an inactive lifestyle and harm their health. Lynne Shinto, N.D., M.P.H., professor of neurology and obstetrics and gynecology in the OHSU School of Medicine, will discuss her research evaluating the safety and effectiveness of complementary and integrative therapies including yoga, meditation and even cooking meals.


Magic mushrooms: Easing depression and anxiety at end of life (May 20)

front facing image of man smiling at camera
Anthony Bossis, Ph.D.

Could the ancient practice of using psychedelic compounds for insight and healing have a legitimate and safe role in today’s health care? Anthony P. Bossis, Ph.D., conducts FDA-approved clinical trials in the reemerging field of psychedelic research. A clinical psychologist and clinical assistant professor of psychiatry at the NYU School of Medicine, he leads research exploring the effects of psilocybin, a naturally occurring compound found in specific species of mushrooms.

More information and tickets.


Previous Story Public invited to learn about breakthrough research, patient care at OHSU Next Story 2019 Macular Degeneration and Vision Expo
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X